Protalix BioTherapeutics Inc (PLX)
1.665
-0.02
(-1.48%)
USD |
NYAM |
Nov 21, 15:38
Protalix BioTherapeutics Price: 1.665 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 1.692 | 1.74 | 1.61 | 1.69 | 817071.0 |
| Nov 19, 2024 | 1.66 | 1.75 | 1.58 | 1.63 | 533660.0 |
| Nov 18, 2024 | 1.42 | 1.72 | 1.40 | 1.66 | 1.786M |
| Nov 15, 2024 | 1.38 | 1.41 | 1.33 | 1.40 | 328811.0 |
| Nov 14, 2024 | 1.26 | 1.41 | 1.26 | 1.41 | 1.466M |
| Nov 13, 2024 | 1.28 | 1.31 | 1.225 | 1.24 | 305071.0 |
| Nov 12, 2024 | 1.22 | 1.34 | 1.20 | 1.32 | 473640.0 |
| Nov 11, 2024 | 1.181 | 1.210 | 1.18 | 1.20 | 215684.0 |
| Nov 08, 2024 | 1.17 | 1.22 | 1.16 | 1.16 | 161887.0 |
| Nov 07, 2024 | 1.19 | 1.24 | 1.16 | 1.16 | 331871.0 |
| Nov 06, 2024 | 1.33 | 1.33 | 1.22 | 1.22 | 139516.0 |
| Nov 05, 2024 | 1.30 | 1.32 | 1.27 | 1.30 | 159051.0 |
| Nov 04, 2024 | 1.26 | 1.36 | 1.26 | 1.28 | 969260.0 |
| Nov 01, 2024 | 1.19 | 1.26 | 1.18 | 1.25 | 294747.0 |
| Oct 31, 2024 | 1.18 | 1.18 | 1.14 | 1.17 | 113348.0 |
| Oct 30, 2024 | 1.18 | 1.18 | 1.17 | 1.17 | 140301.0 |
| Oct 29, 2024 | 1.17 | 1.18 | 1.17 | 1.17 | 127863.0 |
| Oct 28, 2024 | 1.10 | 1.14 | 1.07 | 1.13 | 237286.0 |
| Oct 25, 2024 | 1.03 | 1.09 | 1.03 | 1.08 | 129033.0 |
| Oct 24, 2024 | 1.04 | 1.04 | 1.02 | 1.03 | 48112.00 |
| Oct 23, 2024 | 1.04 | 1.049 | 1.02 | 1.02 | 87294.00 |
| Oct 22, 2024 | 1.06 | 1.085 | 1.01 | 1.06 | 297398.0 |
| Oct 21, 2024 | 1.08 | 1.09 | 1.05 | 1.06 | 187585.0 |
| Oct 18, 2024 | 1.08 | 1.10 | 1.080 | 1.09 | 74901.00 |
| Oct 17, 2024 | 1.10 | 1.11 | 1.080 | 1.09 | 146423.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.81
Minimum
Jan 27 2022
6.45
Maximum
Feb 09 2021
2.095
Average
1.58
Median
Jul 15 2021
Price Benchmarks
| Accuray Inc | 1.87 |
| Aethlon Medical Inc | 0.384 |
| AIM ImmunoTech Inc | 0.211 |
| Perspective Therapeutics Inc | 3.055 |
| Armata Pharmaceuticals Inc | 2.10 |
Price Related Metrics
| PS Ratio | 2.863 |
| Price to Book Value | 3.780 |
| Price to Free Cash Flow | 18.23 |
| Earnings Yield | -9.61% |
| Market Cap | 122.60M |